Pfizer (PFE) Treasury Shares (2009 - 2026)

Pfizer has disclosed Treasury Shares across 18 years of filings, most recently posting $115.2 billion for Q1 2026.

• In Q1 2026, Treasury Shares changed 0.16% year-over-year to $115.2 billion; the TTM figure through Mar 2026 stood at $115.2 billion (changed 0.16% YoY), while the FY2025 annual figure was $115.0 billion, changed 0.22% from the prior year.
• Treasury Shares was little changed at $115.2 billion in Q1 2026, from $115.0 billion in the prior quarter.
• Over the last five years, Treasury Shares for PFE reached as high as $3.9 billion in Q1 2026 and fell as low as $39.0 million in Q2 2022.
• The 5-year median for Treasury Shares is $3.9 billion (2024), against an average of $3.7 billion.
• Annual changes were most pronounced in 2022 — Treasury Shares increased 2.34% — and 2026, when it grew 0.16%.
• A 5-year view of Treasury Shares shows it stood at $114.0 billion in 2022, then gained by 0.45% to $114.5 billion in 2023, then gained by 0.24% to $114.8 billion in 2024, then grew by 0.22% to $115.0 billion in 2025, then climbed by 0.15% to $115.2 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $115.2 billion, $115.0 billion, and $115.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.